Search results for "Histocompatibility"

showing 10 items of 473 documents

HER-2/neu-mediated regulation of components of the MHC class I antigen-processing pathway.

2004

Abstract Because of its amplification and/or overexpression in many human tumors, the HER-2/neu proto-oncogene represents an attractive target for T-cell-mediated vaccination strategies. However, overexpression of oncogenes is often associated with defective expression of components of the MHC class I antigen-processing machinery (APM), thereby resulting in an immune escape phenotype of oncogene-transformed cells. To determine whether HER-2/neu influences the MHC class I antigen-processing pathway, the expression pattern of different APM components was examined in murine in vitro models of constitutive and tetracycline-controlled HER-2/neu expression. In comparison with HER-2/neu− control c…

Regulation of gene expressionMice KnockoutCancer ResearchbiologyMHC class I antigenAntigen processingReceptor ErbB-2T-LymphocytesHistocompatibility Antigens Class ITransporter associated with antigen processing3T3 CellsTransfectionMolecular biologyProto-Oncogene MasCell biologyMiceOncologyTapasinAntigenGene Expression RegulationMHC class Ibiology.proteinAnimalsImmunotherapySignal transduction
researchProduct

Large scale preparation of human MHC class II+ integrin beta(1)+ Tregs.

2010

Abstract The human CD4 + CD25 + FoxP3 + regulatory T cell population (Tregs) contains both MHC class II + and MHC class II − cells. MHC class II + Tregs belong to the integrin α 4 β 1 + subpopulation and exclusively execute contact-dependent suppressive activity. Here we present a method optimized for isolation of these MHC class II expressing Tregs from large leukaphereses products using magnetic microbeads that achieves a reproducible purity of more than 90% and enables the use of this small-sized Treg population in pre-clinical application and basic research.

Regulatory T cellImmunologyPopulationIntegrinchemical and pharmacologic phenomenaIntegrin alpha4beta1T-Lymphocytes RegulatoryT-Lymphocyte SubsetsmedicineImmune ToleranceImmunology and AllergyHumansIL-2 receptorLeukapheresiseducationCells CulturedMHC class IIeducation.field_of_studybiologyImmunomagnetic SeparationHistocompatibility Antigens Class IIInterleukin-2 Receptor alpha SubunitFOXP3hemic and immune systemsForkhead Transcription FactorsT lymphocyteMHC restrictionFlow CytometryCell biologyHigh-Throughput Screening Assaysmedicine.anatomical_structureImmunologyCD4 Antigensbiology.proteinJournal of immunological methods
researchProduct

Oral immunization with HCV-NS3-transformed Salmonella: induction of HCV-specific CTL in a transgenic mouse model.

2001

Abstract Background & Aims: The ability to induce cytotoxic T cells is considered an important feature of a candidate hepatitis C virus (HCV) vaccine. We used an oral immunization strategy with attenuated HCV-NS3–transformed Salmonella typhimurium to deliver DNA directly to the gut-associated lymphoid tissue. Methods: HLA-A2.1 transgenic mice were immunized once with transformed attenuated Salmonella . HCV-specific CD8 + T cells were analyzed in vitro as well as in vivo by challenge of mice with recombinant HCV-NS3 vaccinia virus. Results: Salmonella (10 8 colony-forming units; 20 μg plasmid DNA) induced cytotoxic and IFN-γ–producing CD8 + T cells specific for the immunodominant epitope NS3…

Salmonella typhimuriumViral Hepatitis VaccinesSalmonellavirusesAdministration OralMice TransgenicHepacivirusViral Nonstructural Proteinsmedicine.disease_causeMajor histocompatibility complexEpitopeVirusMicrobiologychemistry.chemical_compoundInterferon-gammaMiceInterferonHLA-A2 AntigenmedicineVaccines DNACytotoxic T cellAnimalsVaccines SyntheticHepatologybiologyGastroenterologyvirus diseasesbiochemical phenomena metabolism and nutritionVirologydigestive system diseaseschemistrybiology.proteinImmunizationVacciniaCD8medicine.drugT-Lymphocytes CytotoxicGastroenterology
researchProduct

Application of DNA techniques for identification using human dental pulp as a source of DNA

1992

Dental pulp tissue could be obtained in most cases from materials obtained under experimental conditions and from forensic casework (air accidents, burned and putrefied bodies). Teeth extracted during dental treatment (n = 30) were stored for 6 weeks and 4 years at room temperature. In addition teeth (n = 10) extracted from jaw fragments that had been stored for 15 years at room temperature, and teeth extracted post mortem from actual identification cases (n = 8) were investigated. Following extraction from dental pulp tissue the DNA concentration was measured by fluorometry. The amount of DNA obtained from the dental pulp tissue of a single tooth varied from 6 micrograms to 50 micrograms D…

Sex Determination AnalysisImmunoblottingDot blotBiologyPolymerase Chain ReactionPathology and Forensic Medicinechemistry.chemical_compoundstomatognathic systemHumansFluorometryDental PulpSouthern blotHistocompatibility TestingDna concentrationSingle toothDNA FingerprintingMolecular biologyBlotBlotting Southernstomatognathic diseaseschemistryEvaluation Studies as TopicDegraded dnaHigh molecular weight dnaDNAForensic DentistryInternational Journal of Legal Medicine
researchProduct

Dacarbazine-mediated upregulation of NKG2D ligands on tumor cells activates NK and CD8 T cells and restrains melanoma growth.

2013

International audience; Dacarbazine (DTIC) is a cytotoxic drug widely used for melanoma treatment. However, the putative contribution of anticancer immune responses in the efficacy of DTIC has not been evaluated. By testing how DTIC affects host immune responses to cancer in a mouse model of melanoma, we unexpectedly found that both natural killer (NK) and CD8(+) T cells were indispensable for DTIC therapeutic effect. Although DTIC did not directly affect immune cells, it triggered the upregulation of NKG2D ligands on tumor cells, leading to NK cell activation and IFNγ secretion in mice and humans. NK cell-derived IFNγ subsequently favored upregulation of major histocompatibility complex cl…

Skin NeoplasmsMelanoma ExperimentalCD8-Positive T-LymphocytesPharmacologyMESH: Antineoplastic Agents AlkylatingLigandsBiochemistryMiceInterleukin 210302 clinical medicineMESH: Up-RegulationMESH: LigandsCytotoxic T cell[ SDV.IMM ] Life Sciences [q-bio]/ImmunologyMESH: AnimalsMESH : Up-RegulationMESH : LigandsMESH : Melanoma ExperimentalMelanomaMESH : Mice NudeMESH : CD8-Positive T-LymphocytesMESH: CD8-Positive T-LymphocytesUp-Regulation3. Good healthDacarbazineKiller Cells NaturalMESH: Melanoma ExperimentalNK Cell Lectin-Like Receptor Subfamily K030220 oncology & carcinogenesisMESH: NK Cell Lectin-Like Receptor Subfamily K[SDV.IMM]Life Sciences [q-bio]/ImmunologyMESH : Killer Cells Naturalmedicine.drugMESH: Killer Cells NaturalMESH: Cell Line Tumor[SDV.IMM] Life Sciences [q-bio]/ImmunologyMESH: Interferon-gammaDacarbazineMESH : Antineoplastic Agents AlkylatingMice NudeMESH : Mice Inbred C57BLDermatologyBiologyMajor histocompatibility complexMESH: DacarbazineInterferon-gamma03 medical and health sciencesImmune systemDownregulation and upregulationMESH: Mice Inbred C57BLCell Line TumorMESH : MicemedicineMESH : NK Cell Lectin-Like Receptor Subfamily KMESH: Mice NudeAnimalsHumansMESH : DacarbazineAntineoplastic Agents AlkylatingMolecular BiologyMESH: MiceMESH : Interferon-gammaMESH: HumansMESH : Cell Line TumorMESH: Skin NeoplasmsMESH : Skin NeoplasmsMESH : HumansCell Biologymedicine.diseaseMESH : Disease Models AnimalMice Inbred C57BLDisease Models Animalbiology.proteinMESH : AnimalsMESH: Disease Models AnimalCD8030215 immunology
researchProduct

An MHC class II-expressing T cell clone presenting conventional antigen lacks the ability to present bacterial superantigen.

1995

We have analyzed the response of rat T cells to myelin basic protein (MBP) and the bacterial superantigen, staphylococcal enterotoxin E (SEE). Rat T cells reactive with MBP can respond to SEE presented by spleen cells but not to SEE presented by LOA, a rat T cell clone that expresses both I-A and I-E MHC class II molecules, even though LOA is much more efficient than splenic APC in the presentation of MBP. The inability of LOA to present superantigen is not due to a structural difference in MHC II molecules between LOA and the splenic APC or to differential expression of major accessory/adhesion molecules, including CD2, CD5, CD4 and CD44, on LOA. The non-responsiveness of SEE/LOA-induced T…

Staphylococcus aureusT cellT-LymphocytesImmunologyAntigen-Presenting CellsEnterotoxinsInterferon-gammaAntigenparasitic diseasesMHC class ImedicineImmunology and AllergyCytotoxic T cellAnimalsClonal AnergyMHC class IIAntigens BacterialSuperantigensbiologyAntigen processingChemistryHistocompatibility Antigens Class IIMyelin Basic ProteinGeneral MedicineMHC restrictionClone CellsRatsmedicine.anatomical_structureRats Inbred LewImmunologybiology.proteinCD8International immunology
researchProduct

Mutations affecting MHC class II binding of the superantigen streptococcal erythrogenic toxin A.

1993

Streptococcal pyrogenic exotoxin A (SPEA) is an important pathogenicity factor of group A streptococci. It is a member of the family of 'superantigens' produced by Staphylococcus aureus and Streptococcus pyogenes, and its T lymphocyte stimulating activity is involved in the pathogenesis of certain diseases caused by pyogenic streptococci. In this study we have generated nine mutant SPEA molecules by substituting amino acids in the regions of homology between different streptococcal and staphylococcal superantigens. An additional mutant was created by deletion of the 10 N-terminal amino acids. The mutants were expressed as fusion proteins. Several mutations led to a loss of function due to a…

Streptococcus pyogenesT-LymphocytesImmunologyMutantMolecular Sequence DataExotoxinsBiologymedicine.disease_causeLymphocyte ActivationMicrobiologyMiceStructure-Activity Relationshipstomatognathic systemBacterial ProteinsSuperantigenmedicineImmunology and AllergyAnimalsHumansAmino Acid SequencePeptide sequencechemistry.chemical_classificationMice Inbred BALB CSuperantigensBase SequenceHistocompatibility Antigens Class IIMembrane ProteinsGeneral Medicinebiology.organism_classificationFusion proteinAmino acidchemistrySpeaStreptococcus pyogenesMutationExotoxinInternational immunology
researchProduct

Development of T cell clones reactive to two defined restriction elements in conjunction with two defined epitopes of antigen

1985

A previously described pig insulin (PI)-specific T cell line of (B10 X B10.BR)F1 origin was assayed for its reactivity with species variants of insulin in the presence of antigen-presenting cells (APC) of various H-2 haplotypes. In addition to its reactivity with PI and bovine insulin (BI) in the context of syngeneic F1 (H-2b X k)-APC, a weak cross-reactivity was observed with parental B10 (H-2b)-APC and BI but not PI. The cross-reactive cells could be selected out by several restimulations with the combination of BI and B10-APC. From the resulting, strongly cross-reactive T cell line several interleukin 2-dependent sublines were developed which did not require antigen-specific restimulatio…

SwineT-LymphocytesT cellImmunologyReceptors Antigen T-CellClone (cell biology)Context (language use)Cross ReactionsLymphocyte ActivationMajor histocompatibility complexEpitopeCell LineEpitopesMiceImmune systemAntigenmedicineAnimalsInsulinImmunology and AllergyGeneticsbiologyHistocompatibility Antigens Class IIT lymphocyteMolecular biologymedicine.anatomical_structurebiology.proteinInterleukin-2CattleEuropean Journal of Immunology
researchProduct

Presentation of insulin and insulin A chain peptides to mouse T cells: involvement of cysteine residues.

1991

The requirements for insulin presentation and recognition by A alpha b A beta b- and A alpha b A beta k-restricted mouse T cells were studied using a variety of derivatives of the insulin A chain. It was found that A chain peptides with irreversibly blocked Cys residues are non-stimulatory for the T cells. This suggests that at least one of the Cys residues is essential for recognition. On the other hand, all A chain peptides containing Cys residues modified in a way reversible by reaction with thiols are stimulatory yet differ in antigenic potency. All these A chain derivatives including a 14 amino acid fragment require uptake by antigen presenting cells (APC) for efficient presentation. D…

Swinemedicine.medical_treatmentT-LymphocytesImmunologyAntigen presentationReceptors Antigen T-CellAntigen-Presenting CellsPeptideMice Inbred StrainsIn Vitro TechniquesCell LineEpitopesMiceAntigenmedicineAnimalsInsulinCysteineAntigen-presenting cellMolecular Biologychemistry.chemical_classificationChemistryInsulinT-cell receptorHistocompatibility Antigens Class IIChloroquineAmino acidBiochemistryCattleInterleukin-3PeptidesCysteineMolecular immunology
researchProduct

BNT162b2 induces SARS-CoV-2-neutralising antibodies and T cells in humans

2020

BNT162b2, a lipid nanoparticle (LNP) formulated nucleoside-modified messenger RNA (mRNA) encoding the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S) stabilized in the prefusion conformation, has demonstrated 95% efficacy to prevent coronavirus disease 2019 (COVID-19). Recently, we reported preliminary BNT162b2 safety and antibody response data from an ongoing placebo-controlled, observer-blinded phase 1/2 vaccine trial1. We present here antibody and T cell responses from a second, non-randomized open-label phase 1/2 trial in healthy adults, 19-55 years of age, after BNT162b2 prime/boost vaccination at 1 to 30 µg dose levels. BNT162b2 elicited strong antibody …

T cellBiologyMajor histocompatibility complexVirologyEpitopeVaccinationImmune systemmedicine.anatomical_structureInterferonmedicinebiology.proteinAntibodyCD8medicine.drug
researchProduct